Immunization with influenza A NP-expressing vaccinia virus recombinant protects mice against experimental infection with human and avian influenza viruses

Archives of Virology

Volumn 151, Issue 5, 2006, Pages 921-931

  Altstein, A D ^a   Gitelman, A K ^b   Smirnov, Y A ^b   Piskareva, L M ^a   Zakharova, L G ^a   Pashvykina, G V ^a   Shmarov, M M ^c   Zhirnov, O P ^b   Varich, N P ^b   Ilyinskii, P O ^d   Shneider, A M ^d  

^a INSTITUTE OF GENE BIOLOGY   (Russian Federation)

^b D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^c GAMALEYA RESEARCH INSTITUTE OF EPIDEMIOLOGY AND MICROBIOLOGY   (Russian Federation)

^d Cure Lab Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; HYBRID PROTEIN; INFLUENZA VACCINE; NP PROTEIN, INFLUENZA A VIRUS; NUCLEOPROTEIN; ORNITHINE CARBAMOYLTRANSFERASE; RECOMBINANT VACCINE; RNA BINDING PROTEIN; VIRUS ANTIBODY;

ANIMAL; ARTICLE; AVIAN INFLUENZA; BAGG ALBINO MOUSE; BIRD; BLOOD; CHICK EMBRYO; DISEASE MODEL; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N2; LUNG; METABOLISM; MOUSE; ORTHOMYXOVIRUS INFECTION; VACCINIA VIRUS; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; BIRDS; CHICK EMBRYO; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N2 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; NUCLEOPROTEINS; ORNITHINE CARBAMOYLTRANSFERASE; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS; VACCINES, SYNTHETIC; VACCINIA VIRUS; VIRAL CORE PROTEINS;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; ORTHOMYXOVIRIDAE; VACCINIA VIRUS;

EID: 33645973276     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-005-0676-9     Document Type: Article

References (35)

1. ME Andrew BE Coupar GL Ada DB Boyle 1986 Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants Microb Pathog 1 443 452
2. ME Andrew BE Coupar DB Boyle GL Ada 1987 The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants Scand J Immunol 25 21 28
3. ME Andrew BE Coupar 1988 Efficacy of influenza haemagglutinin and nucleoprotein as protective antigens against influenza virus infection in mice Scand J Immunol 28 81 85
4. LC Anton U Schubert I Bacik MF Princiotta PA Wearsch J Gibbs PM Day C Realini MC Rechsteiner JR Bennink JW Yewdell 1999 Intracellular localization of proteasomal degradation of a viral antigen J Cell Biol 146 113 124
5. JR Bennink JW Yewdell GL Smith B Moss 1987 Anti-influenza virus cytotoxic T lymphocytes recognize the three viral polymerases and a nonstructural protein: responsiveness to individual viral antigens is major histocompatibility complex controlled J Virol 61 1098 1102
6. VM Braud AJ [tmp] McMichael V Cerundolo 1998 Differential processing of influenza nucleoprotein in human and mouse cells Eur J Immunol 28 625 635
7. Z Chen S Kadowaki Y Hagiwara T Yoshikawa K Matsuo T Kurata S Tamura 2001 Protection against influenza B virus infection by immunization with DNA vaccines Vaccine 19 1446 1455
8. Z Chen Y Sahashi K Matsuo H Asanuma H Takahashi T Iwasaki Y Suzuki C Aizawa T Kurata S Tamura 1998 Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza Vaccine 16 1544 1549
9. Z Chen T Yoshikawa S Kadowaki Y Hagiwara K Matsuo H Asanuma C Aizawa T Kurata S Tamura 1999 Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein J Gen Virol 80 2559 2564
10. AK Gitelman NV Kaverin IG Kharitonenkov IA Rudneva VM Zhdanov 1984 Changes in the antigenic specificity of influenza hemagglutinin in the course of adaptation to mice Virology 134 230 232
11. C Gschoesser G Almanzar U Hainz J Ortin D Schonitzer H Schild M Saurwein-Teissl B Grubeck-Loebenstein 2002 CD4+ and CD8+ mediated cellular immune response to recombinant influenza nucleoprotein Vaccine 20 3731 3738
12. KJ Jakeman H Smith C Sweet 1989 Mechanism of immunity to influenza: maternal and passive neonatal protection following immunization of adult ferrets with a live vaccinia-influenza virus haemagglutinin recombinant but not with recombinants containing other influenza virus proteins J Gen Virol 70 1523 1531
13. NV Kaverin IA Rudneva NA Ilyushina NL Varich AS Lipatov YA Smirnov EA Govorkova AK Gitelman DK Lvov RG Webster 2002 Structure of antigenic sites on the haemagglutinin molecule of H5 avian influenza virus and phenotypic variation of escape mutants J Gen Virol 83 2497 2505
14. Kilbourne ED, Arden NH (1999) Inactivated influenza vaccines. In: Plotkin SA, Orenstein WA (eds) Vaccines. W.B. Saunders Company, Philadelphia, pp 531-551
15. MV Khoretonenko MF Vorovitch LG Zakharova GV Pashvykina NV Ovsyannikova JR Stephenson AV Timofeev AD Altstein AM Shneider 2003 Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice Immunol Lett 90 161 163
16. S Kodihalli DL Kobasa RG Webster 2000 Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines Vaccine 18 2592 2599
17. Lamb RA, Krug RM (2001) Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology, v.1. Lippincot, Williams, Wilkins, Philadelphia, USA, pp 1487-1531
18. AS Lipatov EA Govorkova RJ Webby H Ozaki M Peiris Y Guan L Poon RG Webster 2003 Influenza: emergence and control J Virol (2004) 78 8951 8959
19. P Loetscher G Pratt M Rechsteiner 1991 The C terminus of mouse ornithine decarboxylase confers rapid degradation on dihydrofolate reductase. Support for the pest hypothesis J Biol Chem 266 11213 11220
20. B Moss 1996 Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety Proc Natl Acad Sci USA 93 11341 11348
21. P Potter S Tourdot T Blanchard GL Smith KG Gould 2001 Differential processing and presentation of the H-2D(b)-restricted epitope from two different strains of influenza virus nucleoprotein J Gen Virol 82 1069 1074
22. Rokitsky PF (1964) Biological statistics. Vysshaya shkola, Minsk, USSR (in Russian)
23. LL Shu WJ Bean RG Webster 1993 Analysis of the evolution and variation of the human influenza A virus nucleoprotein gene from 1933 to 1990 J Virol 67 2723 2729
24. YA Smirnov AS Lipatov R Van Beek AK Gitelman AD Osterhaus EC Claas 2000 Characterization of adaptation of an avian influenza A (H5N2) virus to a mammalian host Acta Virol 44 1 8
25. GL Smith JZ Levin P Palese B Moss 1987 Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses Virology 160 336 345
26. I Stephenson KG Nicholson JM Wood MC Zambon JM Katz 2004 Confronting the avian influenza threat: vaccine development for a potential pandemic Lancet Infect Dis 4 499 509
27. L Stitz C Schmitz D Binder R Zinkernagel E Paoletti H Becht 1990 Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection J Gen Virol 71 1169 1179
28. A Townsend J Bastin K Gould G Brownlee M Andrew B Coupar D Boyle S Chan G Smith 1988 Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen J Exp Med 168 1211 1224
29. JB Ulmer 2002 Influenza DNA vaccines Vaccine 20 [Suppl] 2 74 76
30. RG Webster Y Kawaoka J Taylor R Weinberg E Paoletti 1991 Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens Vaccine 9 303 308
31. RD Wesley M Tang KM Lager 2004 Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus Vaccine 22 3427 3434
32. DC Wraith AE Vessey BA Askonas 1987 Purified influenza virus nucleoprotein protects mice from lethal infection J Gen Virol 68 433 440
33. Wright P, Webster RG (2001) Orthomyxoviruses. In: Knipe DM, Howley PM (eds) Fields virology, vol 1. Lippincot, Williams, Wilkins, Philadelphia, USA, pp 1533-1579
34. JW Yewdell JR Bennink GL Smith B Moss 1985 Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes Proc Natl Acad Sci USA 82 1785 1789
35. J Yewdell LC Anton I Bacik U Schubert HL Snyder JR Bennink 1999 Generating MHC class I ligands from viral gene products Immunol Rev 172 97 108